News

Genital Herpes: What Patients Might Not Know


 

"Do not underestimate the impact of this diagnosis on your patients. They will require extensive, thoughtful counseling [because] the physical impact of genital herpes is nothing compared to the psychological one," Ms. Mulcahy said.

Such counseling should include information about the natural history of disease, the ability to bear children, the transmission risk to sexual partners, and the variations in severity of primary vs. recurrent episodes. It also is important to dispel cancer myths, reiterate the fact that the virus can be transmitted in the absence of symptoms or lesions, remind patients of their obligation to inform current and future partners, and recommend counseling and testing for sexual partners, she said.

Risk-reduction strategies also should be discussed, including avoiding sexual contact when symptoms or lesions are present and using latex barrier protection and suppressive therapy. There are three oral antiviral drugs—acyclovir, valacyclovir, and famciclovir—approved for the treatment of genital herpes. Topical treatments, she stressed, "absolutely do not work and have no role in the treatment of genital herpes."

Pages

Recommended Reading

FDA Grants New Cephalosporin Fast-Track Status
MDedge Dermatology
Gonorrhea Treatment 'Hanging by a Thread'
MDedge Dermatology
Norovirus Was Spread Via School Computers
MDedge Dermatology
Data Watch: Total HIV/AIDS Federal Funding in 2006
MDedge Dermatology
Syphilis Infections Jumped 12% From 2006 to 2007
MDedge Dermatology
CDC: Over 3 Million Teen Girls Infected With STD
MDedge Dermatology
Data Strengthen Link Between HPV, Oral Cancer
MDedge Dermatology
HPV Vaccine Cuts Abnormal Pap Smears in 4 Years
MDedge Dermatology
Photodynamic Therapy in Dermatology: An Update on Applications and Outcomes
MDedge Dermatology
Practical Management Tips for Methicillin-Resistant Staphylococcus aureus [editorial]
MDedge Dermatology